Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Allen

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
Chemotherapy|January 1, 1988
Studies on antifungal agents. 18. In vitro activity of 5,5-disubstituted-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methy lisoxazol idines and related compoundsG B Mullen, T R DeCory, S D Allen, et al.
Arzneimittel-Forschung|October 1, 1989
Novel 5-substituted 3-(2-naphthalenyl)-3-(1H-imidazol-l-ylmethy)-2-methylisoxazolidine derivativesG A Bennett, G B Mullen, S D Allen, et al.
Chemotherapy|January 1, 1989
Studies on antifungal agents. 20. Effect of the nitrogen substitution on the in vitro activity of novel 3,5-substituted isoxazolidinesP A Swift, G B Mullen, J T Mitchell, et al.
Chemotherapy|January 1, 1988
Studies on antifungal agents. 17. Effects of the C-5-substitution on the in vitro activity of novel 3,5-substituted isoxazolidinesP A Dormer, G B Mullen, J T Mitchell, et al.
The Journal of the Indiana State Medical Association|December 1, 1983
Prophylaxis of contacts of patients with meningococcal infectionJ W Gaebler, M B Kleiman, J K Reynolds, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro activity of novel cis-5-substituted-3-(2-naphthalenyl)-3-(1H-imidazol-1-ylmethyl)- 2-methylisoxazolidine derivativesG A Bennett, G B Mullen, S D Allen, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1991
Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolatesP C Fuchs, A L Barry, M A Pfaller, et al.
Journal of Clinical Microbiology|August 1, 1992
Haemophilus influenzae ATCC 49766, an alternative quality control strain for monitoring broth microdilution susceptibility tests with selected beta-lactamsA L Barry, J H Jorgensen, D J Hardy, et al.
Bulletin of Environmental Contamination and Toxicology|June 1, 1992
Effect of PCB and DES on rat monoamine oxidase, acetylcholinesterase, testosterone, and estradiol ontogenyD R Vincent, W S Bradshaw, G M Booth, et al.
The American Journal of Medicine|April 1, 1994
Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal floraJ Jansen, M Cromer, L Akard, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
Chemotherapy|January 1, 1988
Studies on antifungal agents. 18. In vitro activity of 5,5-disubstituted-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methy lisoxazol idines and related compoundsG B Mullen, T R DeCory, S D Allen, et al.
Arzneimittel-Forschung|October 1, 1989
Novel 5-substituted 3-(2-naphthalenyl)-3-(1H-imidazol-l-ylmethy)-2-methylisoxazolidine derivativesG A Bennett, G B Mullen, S D Allen, et al.
Chemotherapy|January 1, 1989
Studies on antifungal agents. 20. Effect of the nitrogen substitution on the in vitro activity of novel 3,5-substituted isoxazolidinesP A Swift, G B Mullen, J T Mitchell, et al.
Chemotherapy|January 1, 1988
Studies on antifungal agents. 17. Effects of the C-5-substitution on the in vitro activity of novel 3,5-substituted isoxazolidinesP A Dormer, G B Mullen, J T Mitchell, et al.
The Journal of the Indiana State Medical Association|December 1, 1983
Prophylaxis of contacts of patients with meningococcal infectionJ W Gaebler, M B Kleiman, J K Reynolds, et al.
Annals of the New York Academy of Sciences|January 1, 1988
In vitro activity of novel cis-5-substituted-3-(2-naphthalenyl)-3-(1H-imidazol-1-ylmethyl)- 2-methylisoxazolidine derivativesG A Bennett, G B Mullen, S D Allen, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1991
Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolatesP C Fuchs, A L Barry, M A Pfaller, et al.
Journal of Clinical Microbiology|August 1, 1992
Haemophilus influenzae ATCC 49766, an alternative quality control strain for monitoring broth microdilution susceptibility tests with selected beta-lactamsA L Barry, J H Jorgensen, D J Hardy, et al.
Bulletin of Environmental Contamination and Toxicology|June 1, 1992
Effect of PCB and DES on rat monoamine oxidase, acetylcholinesterase, testosterone, and estradiol ontogenyD R Vincent, W S Bradshaw, G M Booth, et al.
The American Journal of Medicine|April 1, 1994
Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal floraJ Jansen, M Cromer, L Akard, et al.
Pageof 15